UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients

American journal of transplantation, 2012-01, Vol.12 (1), p.210-217

2012

Volltextzugriff (PDF)

Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials

Transplantation proceedings, 2008-06, Vol.40 (5), p.1407-1410

2008

Volltextzugriff (PDF)

Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

American journal of transplantation, 2012-03, Vol.12 (3), p.630-639

2012

Volltextzugriff (PDF)

Belatacept‐Based Immunosuppression in De Novo Liver Transplant Recipients: 1‐Year Experience From a Phase II Randomized Study

American journal of transplantation, 2014-08, Vol.14 (8), p.1817-1827

2014

Volltextzugriff (PDF)

POS1062 THERAPEUTIC POTENTIAL OF IMVOTAMAB, A CD20-TARGETED BISPECIFIC IGM T CELL ENGAGER, FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE DISEASE PATIENTS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.935-935

2024

Volltextzugriff (PDF)

Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study

American journal of transplantation, 2014-08, Vol.14 (8), p.1817-1827

2014

Volltextzugriff (PDF)

Increased neutrophil motility by β-glucan in the absence of chemoattractant

Shock (Augusta, Ga.), 2001-12, Vol.16 (6), p.419-424

2001

Volltextzugriff (PDF)

Long-Term Extension of the Belatacept BENEFIT Study: Results at Month 48: 746

Transplantation, 2012-11, Vol.94 (10S), p.101

2012

Volltextzugriff (PDF)

Long-Term Extension of the Belatacept BENEFIT Study: Results at Month 48: 746

Transplantation, 2012-11, Vol.94 (10S), p.958

2012

Volltextzugriff (PDF)

Long-Term Extension of the Belatacept BENEFIT-EXT Study: Results at Month 48: 760

Transplantation, 2012-11, Vol.94 (10S), p.974

2012

Volltextzugriff (PDF)

Isolated Iliac Artery Dissection Secondary to Fibromuscular Dysplasia: Three Cases in Young Adults

Vascular surgery, 1996-09, Vol.30 (5), p.417-422

1996

Volltextzugriff (PDF)

Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins

The Journal of immunology (1950), 1999-06, Vol.162 (11), p.6792-6799

1999

Volltextzugriff (PDF)

Promotion of Neutrophil Chemotaxis Through Differential Regulation of beta sub(1) and beta sub(2) Integrins

The Journal of immunology (1950), 1999-06, Vol.162 (11), p.6792-6799

1999

Volltextzugriff (PDF)

Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration

Molecular biology of the cell, 1998-10, Vol.9 (10), p.2751-2765

1998

Volltextzugriff (PDF)

Thallium lung-to-heart quantification: three methods of evaluation

Journal of nuclear medicine technology, 1986, Vol.14 (4), p.193-195

1986

Volltextzugriff (PDF)

Prevalence and time course of arrhythmia-induced cardiomyopathy in patients with newly diagnosed heart failure and concomitant tachyarrhythmia – the TACHY-HF pilot trial

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Renal Function at 4 Years in a Phase 2 Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous Calcineurin Inhibitor and Corticosteroid Avoidance in Kidney Transplant Recipients: Abstract# 2157

Transplantation, 2014-07, Vol.98, p.114-115

2014

Volltextzugriff (PDF)

Outcomes at 4 Years in a Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous CNI and Steroid-Avoidance in Kidney Transplant: Abstract# 2162

Transplantation, 2014-07, Vol.98, p.116-117

2014

Volltextzugriff (PDF)

Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT: Abstract# 2163

Transplantation, 2014-07, Vol.98, p.117

2014

Volltextzugriff (PDF)

Canephron N reduced immune cell recruitment in experimental cystitis

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e230-e231

2017

Volltextzugriff (PDF)

138 - Canephron N reduced immune cell recruitment in experimental cystitis

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e230-e231

2017

Volltextzugriff (PDF)

Transjugulare retrograde Portographie

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 1976-06, Vol.124 (6), p.531-534

1976

Volltextzugriff (PDF)

Trans-jugular retrograde portography. Preliminary communication

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 1976-06, Vol.124 (6), p.531

1976

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(23)

Sprache

Englisch
(21)
Deutsch
(2)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients

Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials

Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

Belatacept‐Based Immunosuppression in De Novo Liver Transplant Recipients: 1‐Year Experience From a Phase II Randomized Study

POS1062 THERAPEUTIC POTENTIAL OF IMVOTAMAB, A CD20-TARGETED BISPECIFIC IGM T CELL ENGAGER, FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE DISEASE PATIENTS

Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study

Increased neutrophil motility by β-glucan in the absence of chemoattractant

Long-Term Extension of the Belatacept BENEFIT Study: Results at Month 48: 746

Long-Term Extension of the Belatacept BENEFIT Study: Results at Month 48: 746

Long-Term Extension of the Belatacept BENEFIT-EXT Study: Results at Month 48: 760

Isolated Iliac Artery Dissection Secondary to Fibromuscular Dysplasia: Three Cases in Young Adults

Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins

Promotion of Neutrophil Chemotaxis Through Differential Regulation of beta sub(1) and beta sub(2) Integrins

Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration

Thallium lung-to-heart quantification: three methods of evaluation

Prevalence and time course of arrhythmia-induced cardiomyopathy in patients with newly diagnosed heart failure and concomitant tachyarrhythmia – the TACHY-HF pilot trial

Renal Function at 4 Years in a Phase 2 Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous Calcineurin Inhibitor and Corticosteroid Avoidance in Kidney Transplant Recipients: Abstract# 2157

Outcomes at 4 Years in a Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous CNI and Steroid-Avoidance in Kidney Transplant: Abstract# 2162

Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT: Abstract# 2163

Canephron N reduced immune cell recruitment in experimental cystitis

138 - Canephron N reduced immune cell recruitment in experimental cystitis

Transjugulare retrograde Portographie

Trans-jugular retrograde portography. Preliminary communication

Suchergebnisse filtern